Literature DB >> 17409387

Histone deacetylase inhibitor trichostatin A sustains sodium pervanadate-induced NF-kappaB activation by delaying IkappaBalpha mRNA resynthesis: comparison with tumor necrosis factor alpha.

Julie Horion1, Geoffrey Gloire, Nadia El Mjiyad, Vincent Quivy, Linda Vermeulen, Wim Vanden Berghe, Guy Haegeman, Carine Van Lint, Jacques Piette, Yvette Habraken.   

Abstract

NF-kappaB is a crucial transcription factor tightly regulated by protein interactions and post-translational modifications, like phosphorylation and acetylation. A previous study has shown that trichostatin A (TSA), a histone deacetylase inhibitor, potentiates tumor necrosis factor (TNF) alpha-elicited NF-kappaB activation and delays IkappaBalpha cytoplasmic reappearance. Here, we demonstrated that TSA also prolongs NF-kappaB activation when induced by the insulino-mimetic pervanadate (PV), a tyrosine phosphatase inhibitor that initiates an atypical NF-kappaB signaling. This extension is similarly correlated with delayed IkappaBalpha cytoplasmic reappearance. However, whereas TSA causes a prolonged IKK activity when added to TNFalpha, it does not when added to PV. Instead, quantitative reverse transcriptase-PCR revealed a decrease of ikappabalpha mRNA level after TSA addition to PV stimulation. This synthesis deficit of the inhibitor could explain the sustained NF-kappaB residence in the nucleus. In vivo analysis by chromatin immunoprecipitation assays uncovered that, for PV induction but not for TNFalpha, the presence of TSA provokes several impairments on the ikappabalpha promoter: (i) diminution of RNA Pol II recruitment; (ii) reduced acetylation and phosphorylation of histone H3-Lys(14) and -Ser(10), respectively; (iii) decreased presence of phosphorylated p65-Ser(536); and (iv) reduction of IKKalpha binding. The recruitment of these proteins on the icam-1 promoter, another NF-kappaB-regulated gene, is not equally affected, suggesting a promoter specificity of PV with TSA stimulation. Taken together, these data suggest that TSA acts differently depending on the NF-kappaB pathway and the targeted promoter in question. This indicates that one overall histone deacetylase role is to inhibit NF-kappaB activation by molecular mechanisms specific of the stimulus and the promoter.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409387     DOI: 10.1074/jbc.M609166200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  A novel histone deacetylase inhibitor prevents IL-1beta induced metabolic dysfunction in pancreatic beta-cells.

Authors:  Laura Susick; Thulani Senanayake; Rajakrishnan Veluthakal; Patrick M Woster; Anjaneyulu Kowluru
Journal:  J Cell Mol Med       Date:  2009-08       Impact factor: 5.310

2.  Regulation of GTP-binding protein (Gαs) expression in human myometrial cells: a role for tumor necrosis factor in modulating Gαs promoter acetylation by transcriptional complexes.

Authors:  Steve J Webster; Sarah L Waite; Victoria J Cookson; Averil Warren; Raheela Khan; Saurabh V Gandhi; G Nicholas Europe-Finner; Neil R Chapman
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

Review 3.  Histone deacetylase inhibitors and transplantation.

Authors:  Ran Tao; Edwin F de Zoeten; Engin Ozkaynak; Liqing Wang; Bin Li; Mark I Greene; Andrew D Wells; Wayne W Hancock
Journal:  Curr Opin Immunol       Date:  2007-08-24       Impact factor: 7.486

4.  Proteasome inhibition up-regulates inflammatory gene transcription induced by an atypical pathway of NF-kappaB activation.

Authors:  Sarah J Cullen; Subramaniam Ponnappan; Usha Ponnappan
Journal:  Biochem Pharmacol       Date:  2009-10-14       Impact factor: 5.858

5.  Phosphorylation of p65(RelA) on Ser(547) by ATM represses NF-κB-dependent transcription of specific genes after genotoxic stress.

Authors:  Hélène Sabatel; Emmanuel Di Valentin; Geoffrey Gloire; Franck Dequiedt; Jacques Piette; Yvette Habraken
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

6.  TLR2/4-mediated NF-κB pathway combined with the histone modification regulates β-defensins and interleukins expression by sodium phenyl butyrate in porcine intestinal epithelial cells.

Authors:  Xiujing Dou; Junlan Han; Qiuyuan Ma; Baojing Cheng; Anshan Shan; Nan Gao; Yu Yang
Journal:  Food Nutr Res       Date:  2018-12-06       Impact factor: 3.894

7.  Epigenetic Modulation of TLR4 Expression by Sulforaphane Increases Anti-Inflammatory Capacity in Porcine Monocyte-Derived Dendritic Cells.

Authors:  Xueqi Qu; Christiane Neuhoff; Mehmet Ulas Cinar; Maren Pröll; Ernst Tholen; Dawit Tesfaye; Michael Hölker; Karl Schellander; Muhammad Jasim Uddin
Journal:  Biology (Basel)       Date:  2021-05-31

8.  Regulatory roles for histone deacetylation in IL-1beta-induced nitric oxide release in pancreatic beta-cells.

Authors:  L Susick; R Veluthakal; M V Suresh; T Hadden; A Kowluru
Journal:  J Cell Mol Med       Date:  2007-12-05       Impact factor: 5.310

Review 9.  ADAM10 Site-Dependent Biology: Keeping Control of a Pervasive Protease.

Authors:  Francesca Tosetti; Massimo Alessio; Alessandro Poggi; Maria Raffaella Zocchi
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.